Dr Agarwal's Health Care Q3 Results: Clocks Consolidated Profit At Rs 28.3 Crore
The company had registered a profit after tax of Rs 67.79 crore for the nine-month period ending Dec. 31, 2024, as compared to a profit of Rs 53.73 crore registered in the year ago period.
(Photo Source: Envato)
Dr Agarwal's Health Care Ltd. has logged a consolidated profit of Rs 28.24 crore for the October-December 2024 quarter, the company said. The city-headquartered eye care provider had registered a profit after tax of Rs 22.59 crore during the corresponding quarter of last financial year.
The company had registered a profit after tax of Rs 67.79 crore for the nine-month period ending Dec. 31, 2024, as compared to a profit of Rs 53.73 crore registered in the year ago period.
Commenting on the financial performance, Dr Agarwal's Health Care Ltd. chief executive officer Dr Adil Agarwal said, "We have delivered a robust growth of 29.5% in revenue and 26.3% in Ebitda. We have continued to witness strong growth in both patient footfalls and the number of surgeries performed." "Our commitment to providing exceptional care, along with investments in cutting-edge technology, positions us for long-term success. While we have maintained our growth trajectory, we remain committed to delivering sustainable and steady growth in the coming quarters," Agarwal said.
The total income on a consolidated basis for the October-December 2024 quarter surged to Rs 443.43 crore, from Rs 344.69 crore registered in the corresponding quarter of last financial year.
For the nine-month period ending December 31, 2024, the consolidated total income went up to Rs 1,281.37 crore as compared to Rs 1,007.38 crore registered in the year ago period.
The company had added 42 new facilities during the April-December 2024 period of which 35 new facilities were set up while seven facilities were acquired.
Subsequent to the quarter ending Dec. 31, 2024, Dr Agarwal's Health Care Ltd. said it has completed its Initial Public Offering comprising a fresh issuance of 74,62,686 equity shares with a face value of Rs 1 each and offer for sale of 6,78,42,284 equity shares of face value of Re 1 each. These shares were offered at an issue price of Rs 402 per share, which also included 15,78,399 equity y shares reserved for eligible employees.
The company raised a total of Rs 3,027 crore including Rs 300 crore with respect to fresh issuance of equity shares and the company's equity shares were subsequently listed on the BSE Ltd and the National Stock Exchange with effect from Feb. 4, the company said.
